SAYEDA AKBAR: Open Payments
NPI 1710375860 · EAGAN, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $635 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $57 |
| Novo Nordisk Inc | 3 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Abbott Laboratories | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: JARDIANCE, Ozempic, GVOKE HYPOPEN, FREESTYLE LIBRE 2, Kerendia, INJECTAFER, XIFAXAN, MOUNJARO.
Industry payments across MN — which companies pay providers there.
